Daniel L. Mulkerin

Daniel L. Mulkerin, M.D. serves as Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He practices at the Wilmot Cancer Institute in Webster, NY, specializing in gastrointestinal malignancies with active involvement in clinical research. As part of the University of Rochester Medical Faculty Group (URMFG) and Accountable Health Partners (AHP), he maintains significant regional influence in oncology care delivery.

Dr. Mulkerin's research focuses on gastrointestinal cancers, particularly colorectal and pancreatic malignancies. His work spans clinical trial design, pharmacotherapy optimization, and cancer care delivery systems. Recent publications demonstrate expertise in biomarker-driven therapies, metastatic disease management, and multidisciplinary care models. His clinical trials portfolio includes phase I-III studies investigating novel combinations for pancreatic cancer and neuroendocrine tumors.

• Award for Service/Leadership Excellence (2017-2018)
• UW Health Patient Experience Physician Champion Award (2016, 2014)
• UW Health Physician Excellence Regional Services Award (2015)
• Best Doctors in America (2013-2021)
• Top Doctors: Madison Magazine (2006)

As a highly respected mentor with extensive teaching experience, Dr. Mulkerin contributes significantly to medical education while advancing the Department of Medicine's regional footprint. His leadership extends to optimizing cancer care delivery through initiatives like the National Comprehensive Cancer Network Infusion Efficiency Workgroup. At the Wilmot Cancer Institute, he collaborates within multidisciplinary teams managing complex gastrointestinal malignancies, with particular focus on clinical trial integration into standard care pathways.